Hi, what are you looking for?
Palantir joins list of 20 most valuable U.S. companies, with stock more than doubling in 2025
FCC greenlights Paramount’s $8 billion merger with entertainment group Skydance
Microsoft’s Satya Nadella says job cuts have been ‘weighing heavily’ on him
UnitedHealth says it faces DOJ investigation over Medicare billing practices
Uber will let women drivers and riders request to avoid being paired with men
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
S&P 500 Breaking Out Again: What This Means for Your Portfolio
Momentum Leaders Are Rotating — Here’s How to Find Them
Is META Breaking Out or Breaking Down?
A Wild Ride For the History Books: 2025 Mid-Year Recap
From talk to tactics: Trump pivots on Russia strategy to end war
DNI Tulsi Gabbard declassified Trump-Russia docs: Here’s what they say
FTC firings take spotlight in Trump’s fight to erase independence of agencies
DAVID MARCUS: Zany Zohran endorsement is existential choice for Hakeem Jeffries
Trump signs rescissions package, closes out week with trip to Scotland
Unlock the power of divergence analysis! Join Dave as he breaks down what a bearish momentum divergence is and why it matters. Throughout this video, Dave illustrates how to confirm (or invalidate) the signal on the S&P500, Nasdaq100, equal‑weighted indexes, semiconductors, and even defensive names like AT&T (T).
This video originally premiered on June 10, 2025. Watch on StockCharts’ dedicated David Keller page!
Previously recorded videos from Dave are available at this link.
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...
A nationwide coordinated crackdown on retail crime — what authorities are calling the first of its kind — led to hundreds of arrests in...
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2 and early signs of...
Over the past five sessions, the Indian equity markets headed nowhere and continued consolidating in a defined range. In the previous weekly note, it...
